One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Table of Contents
doi : 10.1016/S1542-3565(21)01313-6
Volume 20, Issue 2, February 2022, Pages A3-A7
Elsewhere in the AGA Journals
doi : 10.1016/S1542-3565(21)01314-8
Volume 20, Issue 2, February 2022, Pages A9-A11
Information for Authors and Readers
doi : 10.1016/S1542-3565(21)01315-X
Volume 20, Issue 2, February 2022, Pages A13-A14
Crohn’s Disease of the Esophagus
Amrit K.KambojSunanda V.KaneCadman L.Leggett
doi : 10.1016/j.cgh.2020.10.032
Volume 20, Issue 2, February 2022, Pages A15-A16
Gastric Pyloric Gland Adenoma in MUTYH-Associated Polyposis
ConanLiu?KarenMatsukuma‡SoorajTejaswi§
doi : 10.1016/j.cgh.2020.10.005
Volume 20, Issue 2, February 2022, Pages A25-A26
Diffuse Hemorrhagic Enterocolitis in the Setting of 2019 Coronavirus
BlancaLizaola-Mayo?MarcelaSalomao‡Jennifer L.Horsley-Silva?
doi : 10.1016/j.cgh.2020.10.011
Volume 20, Issue 2, February 2022, Pages A27-A28
A Rare Case of Heterotaxy Syndrome With Left Isomerism
SarbjotGrewalRupinderMann
doi : 10.1016/j.cgh.2020.08.005
Volume 20, Issue 2, February 2022, Page e11
Gastric Adenocarcinoma and Proximal Polyposis of the Stomach Occurring With Ball Valve Syndrome
SoichiroAkoSeijiKawanoHiroyukiOkada
doi : 10.1016/j.cgh.2020.07.044
Volume 20, Issue 2, February 2022, Pages e12-e13
Lymphangiomatosis of the Colon
ZlatanMujagicAd A.M.MascleeDanielKeszthelyi
doi : 10.1016/j.cgh.2020.08.037
Volume 20, Issue 2, February 2022, Pages e14-e15
A Gastric Submucosal Polypoid Lesion With Whitish Protuberance
ShinKashimaMikihiroFujiyaTakumaGoto
doi : 10.1016/j.cgh.2020.08.039
Volume 20, Issue 2, February 2022, Pages e16-e17
Pembrolizumab-Induced Sclerosing Cholangitis
Ali DeanTahboub Amawi?William J.Tremaine‡Sudhakar K.Venkatesh?
doi : 10.1016/j.cgh.2020.11.048
Volume 20, Issue 2, February 2022, Page e18
Issue Highlights
JaneOnkenMD(Special Section Editor)
doi : 10.1016/j.cgh.2021.11.027
Volume 20, Issue 2, February 2022, Page 251
An Automated Reporting System for Colonoscopy Quality: Lessons in Implementation
Nuzhat A.AhmadShivan J.Mehta
doi : 10.1016/j.cgh.2021.10.001
Volume 20, Issue 2, February 2022, Pages 252-255.e1
Expert Panel Review on Nonalcoholic Fatty Liver Disease in Persons With Human Immunodeficiency Virus
Jordan E.Lake?TurnerOverton‡SusannaNaggie§MarkSulkowski||RohitLoomba¶David E.Kleiner#Jennifer C.Price??Kara W.Chew‡‡Raymond T.Chung§§Kathleen E.Corey§§
doi : 10.1016/j.cgh.2020.10.018
Volume 20, Issue 2, February 2022, Pages 256-268
Clinical Updates in Colorectal Endoscopic Submucosal Dissection
DennisYangPeter V.Draganov
doi : 10.1016/j.cgh.2021.09.025
Volume 20, Issue 2, February 2022, Pages 269-271
Main Pancreatic Duct Dilation in IPMN: When (and Where) to Get “Worried”?
Koushik K.DasMDDaniel K.MulladyMD
doi : 10.1016/j.cgh.2021.02.017
Volume 20, Issue 2, February 2022, Pages 272-275
Fishing for Irritable Bowel Syndrome: Which Alarm Features Weave the Best Net?
JustinBrandlerMDWilliam D.CheyMD
doi : 10.1016/j.cgh.2020.11.020
Volume 20, Issue 2, February 2022, Pages 276-278
Bowel Movement Frequency Linked to Increased Diverticulitis Risk in 2 Prospective Cohort Studies
Anne F.PeeryMD, MSCR
doi : 10.1016/j.cgh.2021.02.002
Volume 20, Issue 2, February 2022, Pages 279-280
The Chicago Classification of Pouchitis: An Important Step Toward a Needed Consensus
MaiaKayalMD, MSRyan C.UngaroMD, MSJean-FredericColombelMD
doi : 10.1016/j.cgh.2021.03.025
Volume 20, Issue 2, February 2022, Pages 281-282
Through-the-Scope Clips Are Indispensable in Treating Deep Mural Injury From Colorectal EMR
Andrew Y.WangMD
doi : 10.1016/j.cgh.2021.02.023
Volume 20, Issue 2, February 2022, Pages e19-e21
Withdrawal Time: Is Nine the New Six?
Lynn F.ButterlyMD
doi : 10.1016/j.cgh.2021.01.035
Volume 20, Issue 2, February 2022, Pages e22-e24
Adenoma Detection Rate: The Gift That Keeps on Giving
Douglas J.RobertsonMD, MPH
doi : 10.1016/j.cgh.2020.11.003
Volume 20, Issue 2, February 2022, Pages e25-e27
Closing the Gap: the Real-World Risk of Serious Infections With Vedolizumab in Comparison With Anti-TNF Therapy in Inflammatory Bowel Disease
WaseemAhmedMDFrank I.ScottMD, MSCE
doi : 10.1016/j.cgh.2021.05.026
Volume 20, Issue 2, February 2022, Pages e28-e30
Incidence of Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-analysis, and Meta-regression
Lorenzo A.Orci?‡aMarcoSanduzzi-Zamparelli§?aBertaCaballol§aVictorSapena§NicolaColucci?¶FerranTorres#??JordiBruix§MaríaReig§bChristianToso?‡b
doi : 10.1016/j.cgh.2021.05.002
Volume 20, Issue 2, February 2022, Pages 283-292.e10
Magnitude and Time-Trend Analysis of Postendoscopy Esophageal Adenocarcinoma: A Systematic Review and Meta-analysis
TarekSawas?Abdul MounaemMajzoub‡JamesHaddad?ThomasTielleman?TarekNayfeh‡RenaYadlapati§SiddharthSingh§JenniferKolb?Ravy K.Vajravelu¶David A.Katzka#SachinWani??Post-Endoscopy Esophageal Adenocarcinoma Consensus Panel
doi : 10.1016/j.cgh.2021.04.032
Volume 20, Issue 2, February 2022, Pages e31-e50
Endoscopic Phenotype of the J Pouch in Patients With Inflammatory Bowel Disease: A New Classification for Pouch Outcomes
ShintaroAkiyama?Jacob E.Ollech?VictoriaRai?Laura R.Glick?YangtianYi?CindyTraboulsi?JosephRunde†Russell D.Cohen?Kinga B.Skowron§Roger D.Hurst§KonstantinUmanskiy§Benjamin D.Shogan§Neil H.Hyman§Michele A.Rubin§Sushila R.Dalal?AtsushiSakuraba?JoelPekow?Eugene B.Chang?David T.Rubin??
doi : 10.1016/j.cgh.2021.02.010
Volume 20, Issue 2, February 2022, Pages 293-302.e9
Dietary Gluten Intake Is Not Associated With Risk of Inflammatory Bowel Disease in US Adults Without Celiac Disease
Emily W.Lopes?BenjaminLebwohl‡§Kristin E.Burke?Kerry L.Ivey?¶#Ashwin N.Ananthakrishnan???PaulLochhead?James M.Richter?Jonas F.Ludvigsson‡‡§§Walter C.Willett¶??¶¶Andrew T.Chan???¶¶HamedKhalili???##
doi : 10.1016/j.cgh.2021.03.029
Volume 20, Issue 2, February 2022, Pages 303-313.e6
Risk of Serious Infections With Vedolizumab Versus Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease
JulienKirchgesner?‡Rishi J.Desai?LaurentBeaugerie‡SebastianSchneeweiss?Seoyoung C.Kim?§
doi : 10.1016/j.cgh.2020.12.030
Volume 20, Issue 2, February 2022, Pages 314-324.e16
Frequency of Bowel Movements and Risk of Diverticulitis
ManolJovani?‡§WenjieMa?‡KyleStaller?‡Amit D.Joshi?‡Po-HongLiu?‡Long H.Nguyen?‡PaulLochhead?‡YinCao||IdyTam¶KanaWu#Edward L.Giovannucci#??‡‡Lisa L.Strate§§aAndrew T.Chan?‡??||||a
doi : 10.1016/j.cgh.2021.01.003
Volume 20, Issue 2, February 2022, Pages 325-333.e5
Diagnostic Yield of Colonoscopy in Patients With Symptoms Compatible With Rome IV Functional Bowel Disorders
ZohaibAsghar?‡MoThoufeeq?MatthewKurien?‡Alex J.Ball?AnupamRej?Foong WayDavid Tai?ShimaAfify?ImranAziz?‡
doi : 10.1016/j.cgh.2020.08.062
Volume 20, Issue 2, February 2022, Pages 334-341.e3
Epidemiologic and Economic Burden of Achalasia in the United States
Charles E.Gaber?SwathiEluri‡Cary C.Cotton?‡Paula D.Strassle§Timothy M.Farrell§Jennifer L.Lund?Evan S.Dellon‡
doi : 10.1016/j.cgh.2021.02.035
Volume 20, Issue 2, February 2022, Pages 342-352.e5
Racial and Ethnic Disparities in Germline Genetic Testing of Patients With Young-Onset Colorectal Cancer
PoojaDharwadkar?GarrettGreenan?Elena M.Stoffel‡EzraBurstein?§SaraPirzadeh-Miller§SayoniLahiri§CaitlinMauer§Amit G.Singal?§||aCaitlin C.Murphy?§||a
doi : 10.1016/j.cgh.2020.12.025
Volume 20, Issue 2, February 2022, Pages 353-361.e3
The Role of Clips in Preventing Delayed Bleeding After Colorectal Polyp Resection: An Individual Patient Data Meta-Analysis
Ayla S.Turan?HeikoPohl‡MioMatsumoto§Brian S.Lee||MasatoAizawa¶FedericoDesideri#??EduardoAlbéniz‡‡Gottumukkala S.Raju§§DanielLuba||||MaximilienBarret¶¶Suryakanth R.Gurudu##Francisco C.Ramirez##Wey-RanLin???FemkeAtsma‡‡‡Peter D.Siersema?Erwin J.M.van Geenen?
doi : 10.1016/j.cgh.2021.05.012
Volume 20, Issue 2, February 2022, Pages 362-371.e23
Two vs One Forward View Examination of Right Colon on Adenoma Detection: An International Multicenter Randomized Trial
Raymond S.Y.Tang?Jonathan W.J.Lee‡Li-ChunChang§David E.H.Ong‡Han-MoChiu§TakahisaMatsuda||Hyun-SooKim¶MasauSekiguchi||Rupert W.Leong#??Andrew M.Y.Ho?Thomas Y.T.Lam?Yee KitTse?LucyLin‡‡Khay-GuanYeoh‡James Y.W.Lau?§§Joseph J.Y.Sung?Asia Pacific Working Group on Colorectal Cancer Screening
doi : 10.1016/j.cgh.2020.10.014
Volume 20, Issue 2, February 2022, Pages 372-380.e2
Restarting Warfarin vs Direct Oral Anticoagulants After Major Gastrointestinal Bleeding and Associated Outcomes in Atrial Fibrillation: A Cohort Study
NatalieTapaskar?Sandra A.Ham‡DejanMicic§NeilSengupta§
doi : 10.1016/j.cgh.2020.11.029
Volume 20, Issue 2, February 2022, Pages 381-389.e9
Utility and Cost-Effectiveness of a Nonendoscopic Approach to Barrett’s Esophagus Surveillance After Endoscopic Therapy
SwathiEluri?‡aAnnaPaterson§bBrianna N.Lauren||MariaO’Donovan§PradeepBhandari¶Massimilianodi Pietro§MinyiLee||RehanHaidry#LaurenceLovat#KrishRagunath??ChinHur||Rebecca C.Fitzgerald§bNicholas J.Shaheen?‡b
doi : 10.1016/j.cgh.2021.02.013
Volume 20, Issue 2, February 2022, Pages e51-e63
Validation of the Short-Form Esophageal Hypervigilance and Anxiety Scale
Tiffany H.Taft?LiviaGuadagnoli‡Dustin A.Carlson?WalterKou?LaurieKeefer§JohnPandolfino?
doi : 10.1016/j.cgh.2020.12.021
Volume 20, Issue 2, February 2022, Pages e64-e73
Comparative Risk of Serious Infections With Tumor Necrosis Factor ? Antagonists vs Vedolizumab in Patients With Inflammatory Bowel Diseases
SiddharthSingh?‡Herbert C.Heien§JephHerrin||Parambir S.Dulai?LindseySangaralingham§Nilay D.Shah§¶William J.Sandborn?
doi : 10.1016/j.cgh.2021.02.032
Volume 20, Issue 2, February 2022, Pages e74-e88
Overlap of Rome IV Irritable Bowel Syndrome and Functional Dyspepsia and Effect on Natural History: A Longitudinal Follow-Up Study
BrigidaBarberio?YanYiannakou‡Lesley A.Houghton§Christopher J.Black§?Edoardo V.Savarino?Alexander C.Ford§?
doi : 10.1016/j.cgh.2021.04.011
Volume 20, Issue 2, February 2022, Pages e89-e101
Natural History of Perianal Crohn's Disease: Long-term Follow-up of a Population-Based Cohort
CharlèneBrochard?Marie-LaureRabilloud‡StéphanieHamonic§EmmaBajeux§MaëlPagenault‡AlainDabadie||AgatheGerfaud¶Jean-FrançoisViel§IsabelleTron#MichelRobaszkiewicz??Jean-FrançoisBretagne‡LaurentSiproudhis?GuillaumeBouguen?
doi : 10.1016/j.cgh.2020.12.024
Volume 20, Issue 2, February 2022, Pages e102-e110
Cancer Risk in 47,241 Individuals With Celiac Disease: A Nationwide Cohort Study
BenjaminLebwohl?‡Peter H.R.Green?LouiseEmilsson§?¶#KarlMårild??‡‡JonasSöderling§§BjornRoelstraete?Jonas F.Ludvigsson????
doi : 10.1016/j.cgh.2021.05.034
Volume 20, Issue 2, February 2022, Pages e111-e131
Safety and Efficacy of Cold Snare Polypectomy Without Submucosal Injection for Large Sessile Serrated Lesions: A Prospective Study
YoshiakiKimoto?EijiSakai‡RinInamoto?MarieKurebayashi?SyunyaTakayanagi?TomoyaHirata§YuichiroSuzuki?RindoIshii?TakafumiKonishi||KeisukeKanda¶RyojuNegishi?MaikoTakita?KoheiOno?YoheiMinato?TakashiMuramoto?KenOhata?
doi : 10.1016/j.cgh.2020.10.053
Volume 20, Issue 2, February 2022, Pages e132-e138
Outcomes of Deep Mural Injury After Endoscopic Resection: An International Cohort of 3717 Large Non-Pedunculated Colorectal Polyps
IddoBar-Yishay?aNealShahidi?‡§aSunilGupta?‡SergeiVosko?W. Arnoutvan Hattem?ScottSchoeman?MayenaazSidhu?‡David J.Tate??Luke F.Hourigan¶#RajvinderSingh??AlanMoss‡‡Spiro C.Raftopoulos§§GregorBrown??¶¶SimonZanati‡‡¶¶Steven J.Heitman##Eric Y.T.Lee?‡NicholasBurgess?‡Stephen J.Williams?‡KarenByth???‡‡‡Michael J.Bourke?‡
doi : 10.1016/j.cgh.2021.01.007
Volume 20, Issue 2, February 2022, Pages e139-e147
Higher Adenoma Detection Rates at Screening Associated With Lower Long-Term Colorectal Cancer Incidence and Mortality
Amanda J.Cross?Emma C.Robbins?Brian P.Saunders‡Stephen W.Duffy§KateWooldrage?
doi : 10.1016/j.cgh.2020.09.020
Volume 20, Issue 2, February 2022, Pages e148-e167
Impact of 9-Minute Withdrawal Time on the Adenoma Detection Rate: A Multicenter Randomized Controlled Trial
ShengbingZhao?aXiaYang‡aShulingWang?aQianqianMeng?aRundongWang?aLuminBo?aXinChang?PengPan?TianXia?FanYang?JunYao§JinghuaZheng?JianqiuSheng¶XiaojunZhao¶ShanTang¶YaliWang#YipingWang#AixiaGong??WeigangChen‡‡JianweiShen§§XianZhu§§ShaofengWang??CaiwenYan??YoulinYang¶¶YangbeiZhu##Rui-JunMa???RongWang???YingcaiMa‡‡‡ZhaoshenLi?YuBai?
doi : 10.1016/j.cgh.2020.11.019
Volume 20, Issue 2, February 2022, Pages e168-e181
Main Duct Thresholds for Malignancy Are Different in Intraductal Papillary Mucinous Neoplasms of the Pancreatic Head and Body-Tail
StefanoCrippa?‡FrancescaAleotti?‡EnricoLongo?‡GiulioBelfiori?‡StefanoPartelli?‡DomenicoTamburrino?FrancescaDi Salvo?FrancescoDe Cobelli‡§LuigiRomano?Paolo GiorgioArcidiacono‡¶Maria ChiaraPetrone¶GiuseppeZamboni#Marco SchiavoLena??ClaudioDoglioni‡??MassimoFalconi?‡
doi : 10.1016/j.cgh.2020.12.028
Volume 20, Issue 2, February 2022, Pages 390-399.e7
Reliability Criteria of Two-Dimensional Shear Wave Elastography: Analysis of 4277 Measurements in 788 Patients
AnitaPaisant?‡SylvainLemoine?ChristopheCassinotto§Victorde Lédinghen?MaximeRonot¶MarieIrlès-Depé?ValérieVilgrain¶BrigitteLe Bail#ValérieParadis??Clémence M.Canivet‡‡‡SophieMichalak‡§§Marie-ChristineRousselet‡§§Pierre-EmmanuelRautou??JérômeLebigot?‡GillesHunault‡AnneCrouan?ChristopheAubé?‡JérômeBoursier‡‡‡
doi : 10.1016/j.cgh.2020.12.013
Volume 20, Issue 2, February 2022, Pages 400-408.e10
Patterns of Alcohol Use After Early Liver Transplantation for Alcoholic Hepatitis
Brian P.Lee?aGene Y.Im‡aJohn P.Rice§AnnLazar?EthanWeinberg||HyosunHan¶HaripriyaMaddur#R. MarkGhobrial??GeorgeTherapondos‡‡ChristineHsu§§Oren K.Fix||||SheilaEswaran¶¶KirtiShetty##JagChhatwal???Ozden O.Dalgic???NehaJakhete##ConstanceMobley??David W.Victor??NeilMehta?LisanneDinges||||MaryRinella#Thomas D.Schiano‡Michael R.Lucey§NorahTerrault¶
doi : 10.1016/j.cgh.2020.11.024
Volume 20, Issue 2, February 2022, Pages 409-418.e5
Impact of Medicaid Expansion on Liver-Related Mortality
Smriti RajitaKumar?Sameed Ahmed M.Khatana‡DavidGoldberg§
doi : 10.1016/j.cgh.2020.11.042
Volume 20, Issue 2, February 2022, Pages 419-426.e1
Tenofovir Alafenamide for Drug-Resistant Hepatitis B: A Randomized Trial for Switching From Tenofovir Disoproxil Fumarate
Kwan SooByun?aJonggiChoi‡aJi-HoonKim?Yung SangLee‡Han ChuLee‡Yoon JunKim§Byung ChulYoo?So YoungKwon?Geum-YounGwak¶Young-SukLim‡
doi : 10.1016/j.cgh.2021.04.045
Volume 20, Issue 2, February 2022, Pages 427-437.e5
Long-term Patient-Centered Outcomes in Cirrhotic Patients With Chronic Hepatitis C After Achieving Sustained Virologic Response
Zobair M.Younossi?‡§AndreiRacila?‡AndrewMuir||MarcBourliere¶AlessandraMangia#RafaelEsteban??StefanZeuzem‡‡MassimoColombo§§MichaelManns||||George V.Papatheodoridis¶¶MariaButi??AnandChokkalingam##AnujGaggar##FatemaNader???IssahYounossi???LindaHenry???MariaStepanova???
doi : 10.1016/j.cgh.2021.01.026
Volume 20, Issue 2, February 2022, Pages 438-446
Superiority of Self-Expandable Metallic Stents Over Plastic Stents in Treatment of Malignant Distal Biliary Strictures
SungukJang?TylerStevens?Mansour A.Parsi‡AmitBhatt?AdamKichler§John J.Vargo?
doi : 10.1016/j.cgh.2020.12.020
Volume 20, Issue 2, February 2022, Pages e182-e195
Alterations in the Duodenal Fluid Microbiome of Patients With Pancreatic Cancer
ShiroKohi?AnneMacgregor-Das?MohamadDbouk?TakeichiYoshida?MiguelChuidian?ToshiyaAbe?MichaelBorges?Anne MarieLennon‡Eun JiShin‡§Marcia IreneCanto‡§MichaelGoggins?‡§
doi : 10.1016/j.cgh.2020.11.006
Volume 20, Issue 2, February 2022, Pages e196-e227
The tumor microbiome of patients with pancreas ductal adenocarcinoma (PDAC) includes bacteria normally present in the upper gastrointestinal tract. If the predominant source of intratumoral bacteria in patients with PDAC is retrograde migration from the duodenum, duodenal fluid could be a representative biospecimen for determining microbiome profiles of patients with PDAC or at risk of developing PDAC.
Switching to or Add-on Peginterferon in Patients on Nucleos(t)ide Analogues for Chronic Hepatitis B: The SWAP RCT
Seng GeeLim?‡Wei LynYang§Jing HiengNgu?JasonChang?JessicaTan¶TaufiqueAhmed#Yock YoungDan?‡KieronLim??Yin MeiLee?Guan HueiLee?Poh SengTan?Khin LayWai‡‡§§Wah WahPhyo?Htet Htet Toe WaiKhine?ChrisLee?AmyTay?EdwinChan§§??
doi : 10.1016/j.cgh.2021.04.031
Volume 20, Issue 2, February 2022, Pages e228-e250
Clinical Course of Porto-Sinusoidal Vascular Disease Is Distinct From Idiopathic Noncirrhotic Portal Hypertension
KatharinaWöran?aGeorgSemmler‡§||¶aMathiasJachs‡§||¶BenediktSimbrunner‡§||¶#??David Josef MariaBauer‡§¶TeresaBinter‡§KatharinaPomej‡Albert FriedrichStättermayer‡§||PhilippSchwabl‡§¶TheresaBucsics‡§RafaelPaternostro‡§KatharinaLampichler‡‡MatthiasPinter‡§||MichaelTrauner‡||MattiasMandorfer‡§||¶JudithStift?ThomasReiberger‡§||¶#??BernhardScheiner‡§||¶
doi : 10.1016/j.cgh.2020.11.039
Volume 20, Issue 2, February 2022, Pages e251-e266
Racial and Ethnic Disparities in Survival Among Patients With Hepatocellular Carcinoma in the United States: A Systematic Review and Meta-Analysis
Nicole E.Rich?‡ChristianCarr?Adam C.Yopp?‡Jorge A.Marrero?‡Amit G.Singal?‡
doi : 10.1016/j.cgh.2020.12.029
Volume 20, Issue 2, February 2022, Pages e267-e288
Trajectory of Serum Bilirubin Predicts Spontaneous Recovery in a Real-World Cohort of Patients With Alcoholic Hepatitis
RichardParker?JoaquinCabezas‡§JoseAltamirano||Juan PabloArab¶#MeritxellVentura-Cots??AshishSinha‡‡AshwinDhanda§§MarcoArrese¶||||C. AnneMcCune‡‡Ian A.Rowe?BerndSchnabl¶¶PhillipeMathurin##DebbieShawcross???Juan G.Abraldes‡‡‡Michael R.Lucey§§§GuadalupeGarcia-Tsao||||||¶¶¶ElizabethVerna###Robert S.BrownJr.????FranciscoBosques-Padilla‡‡‡‡VictorVargas§§§§AlexandreLouvet###Andrew P.Holt||||||||aRamonBataller??a
doi : 10.1016/j.cgh.2021.01.042
Volume 20, Issue 2, February 2022, Pages e289-e297
Modeling Endoscopic Improvement after Induction Treatment With Mesalamine in Patients With Mild-to-Moderate Ulcerative Colitis
ChristopherMa?‡§JennyJeyarajah§LeonardoGuizzetti§Claire E.Parker§SiddharthSingh?¶Parambir S.Dulai?Geert R.D’Haens§#William J.Sandborn§?Brian G.Feagan§??‡‡VipulJairath§??‡‡
doi : 10.1016/j.cgh.2020.11.040
Volume 20, Issue 2, February 2022, Pages 447-454.e1
Risk and Time Pattern of Recurrences After Local Endoscopic Resection of T1 Colorectal Cancer: A Meta-analysis
HaoDang?NikDekkers?Saskiale Cessie‡Jeanin E.van Hooft?Monique E.van Leerdam?Philip P.Oldenburg?LouisFlothuis?Jan W.Schoones§Alexandra M.J.Langers?James C.H.Hardwick?Joleinvan der Kraan?Jurjen J.Boonstra?
doi : 10.1016/j.cgh.2020.11.032
Volume 20, Issue 2, February 2022, Pages e298-e314
Vedolizumab Therapy in Refractory Microscopic Colitis: A Single Center Case Series
Lindsey C.Shipley?SujanRavi‡Kirk B.Russ‡Frederick H.WeberJr.‡
doi : 10.1016/j.cgh.2021.02.037
Volume 20, Issue 2, February 2022, Pages 455-457
Prevalence and Factors Associated With Statin Use Among Patients With Nonalcoholic Fatty Liver Disease in the TARGET-NASH Study
Mary J.Thomson?aMarinaSerper‡aVandanaKhungar‡L. MichaelWeiss§HuyTrinh||RobertoFirpi-Morell¶MichaelRoden#??‡‡RohitLoomba§§A. SidneyBarrittIV||||DerekGazis¶¶Andrea R.Mospan¶¶Michael W.Fried¶¶K. RajenderReddy‡Anna S.Lok##
doi : 10.1016/j.cgh.2021.03.031
Volume 20, Issue 2, February 2022, Pages 458-460.e4
Safety and Efficacy of Ustekinumab in the Inflammatory Bowel Disease of Chronic Granulomatous Disease
SumonaBhattacharya?Beatriz E.Marciano‡Harry L.Malech§MarthaQuezado||Steven M.Holland¶Suk SeeDe Ravin§Christa S.Zerbe¶TheoHeller#
doi : 10.1016/j.cgh.2021.03.039
Volume 20, Issue 2, February 2022, Pages 461-464.e2
Patients With Low Drug Levels or Antibodies to a Prior Anti–Tumor Necrosis Factor Are More Likely to Develop Antibodies to a Subsequent Anti–Tumor Necrosis Factor
NielsVande Casteele?Maria T.Abreu‡SarahFlier§KonstantinosPapamichael§FlorianRieder||Mark S.Silverberg¶ReenaKhanna#LaurenOkada??LeiYang??AnjaliJain??Adam S.Cheifetz§
doi : 10.1016/j.cgh.2021.01.006
Volume 20, Issue 2, February 2022, Pages 465-467.e2
NAFLD Cirrhosis Is Rising Among Childbearing Women and Is the Most Common Cause of Cirrhosis in Pregnancy
MonikaSarkar?MayaDjerboua‡Jennifer A.Flemming‡§
doi : 10.1016/j.cgh.2021.01.022
Volume 20, Issue 2, February 2022, Pages e315-e318
Long-term Outcomes in Asymptomatic Ulcerative Colitis Diagnosed During Screening Colonoscopy
TakeshiOkamotoKatsuyukiFukuda
doi : 10.1016/j.cgh.2021.03.011
Volume 20, Issue 2, February 2022, Pages e319-e325
The Durability of EUS-Guided Chemoablation of Mucinous Pancreatic Cysts: A Long-Term Follow-Up of the CHARM trial
CourtneyLester?LeonardWalsh‡Kayla M.Hartz‡AbrahamMathew?John M.Levenick?Brandy D.Headlee?Heather D.Heisey§James H.Birkholz||MatthewDixon¶Jennifer L.Maranki?Niraj J.Gusani¶Charles E.Dye?Matthew T.Moyer?
doi : 10.1016/j.cgh.2021.03.041
Volume 20, Issue 2, February 2022, Pages e326-e329
Declining US Hepatocellular Carcinoma Rates, 2014–2017
Meredith S.ShielsThomas R.O’Brien
doi : 10.1016/j.cgh.2021.02.011
Volume 20, Issue 2, February 2022, Pages e330-e334
Exam 1: Magnitude and Time-Trend Analysis of Postendoscopy Esophageal Adenocarcinoma: A Systematic Review and Meta-analysis
doi : 10.1016/j.cgh.2021.11.028
Volume 20, Issue 2, February 2022, Pages e335-e336
Exam 2: Risk of Serious Infections With Vedolizumab Versus Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease
doi : 10.1016/j.cgh.2021.11.025
Volume 20, Issue 2, February 2022, Pages e337-e338
What is the Real Impact of Corticosteroids in the Contemporary Treatment of Crohn’s Disease?
KarimeLucas UemuraMDNatáliaSousa Freitas QueirozMD, PHDCharlie W.LeesFRCP(ED), PHD
doi : 10.1016/j.cgh.2021.03.016
Volume 20, Issue 2, February 2022, Pages 468-469
Reply
EugeniaShmidtMDDavid M.FaleckMDJean-FredericColombelMD
doi : 10.1016/j.cgh.2021.04.010
Volume 20, Issue 2, February 2022, Page 469
A Patient Perspective on Contemporary Risk of Surgery in Patients With Ulcerative Colitis and Crohn’s Disease
KatelinRothBSJeffrey A.BerinsteinMD, MSc
doi : 10.1016/j.cgh.2021.04.012
Volume 20, Issue 2, February 2022, Pages 469-470
Fatty Liver and Type 2 Diabetes Mellitus Regression: The Weight, the Fat, and the Alcohol
AlexanderNg
doi : 10.1016/j.cgh.2021.03.013
Volume 20, Issue 2, February 2022, Page 471
Reply
HajimeYamazakiMD, PhDJuiWangMSYosukeYamamotoMD, PhD
doi : 10.1016/j.cgh.2021.03.051
Volume 20, Issue 2, February 2022, Page 472
Maintenance Therapy in Crohn’s Disease: Does the Drug Matter?
AlexanderNg
doi : 10.1016/j.cgh.2021.04.002
Volume 20, Issue 2, February 2022, Pages 472-473
Reply
EmmaCalabreseMD, PhDFrancescaZorziMD, PhDGiovanniMonteleoneMD, PhD
doi : 10.1016/j.cgh.2021.05.007
Volume 20, Issue 2, February 2022, Pages 473-474
Effects of Tenofovir vs Entecavir on Risk of Hepatocellular Carcinoma in Patients With CHB: A Comment for Moving Forward
Bao-HongYuanMDYan-KunZhuMDRu-HongLiMD
doi : 10.1016/j.cgh.2021.03.014
Volume 20, Issue 2, February 2022, Page e342
Reply
Won-MookChoiMD, PhDJonggiChoiMD, PhDYoung-SukLimMD, PhD
doi : 10.1016/j.cgh.2021.03.035
Volume 20, Issue 2, February 2022, Pages e342-e343
Dietary Treatment of Crohn's Disease in Adults
John OakleyHunterMA, MD
doi : 10.1016/j.cgh.2021.04.036
Volume 20, Issue 2, February 2022, Page e343
Predictive Scores in Acute Severe Ulcerative Colitis: Which, What, and When are the Decision Points We Should Target?
DannyConBSc, MD, MBiostatAbhinavVasudevanBMed, MPH, PhDDaniel R.van LangenbergMBBS, PhD
doi : 10.1016/j.cgh.2021.04.035
Volume 20, Issue 2, February 2022, Pages e344-e345
Reply
JulienKirchgesnerMD, PhDLaurentBeaugerieMD, PhD
doi : 10.1016/j.cgh.2021.05.047
Volume 20, Issue 2, February 2022, Page e345
Predictive Value of Bowel Ultrasound in Crohn’s Disease
XiaoyingHuangMMXiaofeiLIMM
doi : 10.1016/j.cgh.2021.04.040
Volume 20, Issue 2, February 2022, Pages e345-e346
Reply
MariangelaAlloccaMD, PhDSilvioDaneseMD, PhD
doi : 10.1016/j.cgh.2021.05.036
Volume 20, Issue 2, February 2022, Page e346
